BECTON DICKINSON & CO cotiza a 187.37 USD y tiene una capitalización bursátil de $51.0B. En los últimos 12 meses ha facturado $20.8B con un margen de flujo de caja libre del 12.2%. Cotiza a 18.7 veces su flujo de caja libre (P/FCF) y a un PER de 54.2. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essent…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $3.23 | $2.90 | $2.91 |
| Estimado | $4.07 | $3.14 | $2.77 | $2.80 |
| Sorpresa | — | +2.9% | +4.7% | +3.9% |
| Métrica | BDX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 45.4% | 57.0% | -11.6% |
| Operating Margin | 11.8% | -38.6% | +50.4% |
| Net Margin | 7.7% | -33.6% | +41.2% |
| FCF Margin | 12.2% | -13.9% | +26.1% |
| ROE | 6.6% | -40.4% | +47.0% |
| ROA | 3.0% | -32.0% | +35.0% |
| Current Ratio | 1.11 | 2.84 | -1.73 |
| Debt / Equity | 0.69 | 0.28 | +0.41 |